Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?

Category: Ankle; Ankle Arthritis Introduction/Purpose: The utilization of total ankle arthroplasty has increased over the past decade, including bilateral TARs. The risk-benefit profiles of staged versus simultaneous joint arthroplasty continues to be debated in the literature. Previous studies of t...

Full description

Bibliographic Details
Main Authors: Amanda N. Fletcher MD, Gregory F. Pereira MD, Mark E. Easley MD, James A. Nunley MD, James K. DeOrio MD
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011420S00211
_version_ 1819004146414518272
author Amanda N. Fletcher MD
Gregory F. Pereira MD
Mark E. Easley MD
James A. Nunley MD
James K. DeOrio MD
author_facet Amanda N. Fletcher MD
Gregory F. Pereira MD
Mark E. Easley MD
James A. Nunley MD
James K. DeOrio MD
author_sort Amanda N. Fletcher MD
collection DOAJ
description Category: Ankle; Ankle Arthritis Introduction/Purpose: The utilization of total ankle arthroplasty has increased over the past decade, including bilateral TARs. The risk-benefit profiles of staged versus simultaneous joint arthroplasty continues to be debated in the literature. Previous studies of the hip and knee have demonstrated simultaneous bilateral surgery is associated with shorter hospitalization, shorter recovery and rehabilitation time, and decreased cost without increasing perioperative morbidity or mortality. There are limited case series reporting outcomes after bilateral TAR with no previous comparison of simultaneous versus staged TAR. Thus, we aim to compare our experience with bilateral simultaneous versus staged TARs including perioperative complications and patient reported outcomes. Methods: We performed a retrospective study on 62 patients (124 ankles) undergoing primary TAA (CPT 27702) from 2008 at a single academic center. Inclusion criteria were primary bilateral TAA performed in staged or simultaneous fashion in patients over the age of 18 years-old. Exclusion criteria were patients with less than one-year follow-up. Patient demographics, comorbidities, concomitant procedures, perioperative complications, and patient reported outcomes were also collected. Patient reported outcomes included preoperative and postoperative visual analog scale (VAS) for pain, the Short Form-36 (SF-36) Health Survey, the American Orthopaedic Foot & Ankle Society (AOFAS) score, the Foot and Ankle disability Index (FADI) score, and the Short Musculoskeletal Function Assessment (SMFA) bother and function sub-scores. Every patient had separate outcome scores available for each ankle. Univariate and multivariable tests of significance were used to relate patient and operative characteristics to outcomes. Separate subgroup analyses were performed comparing stages versus simultaneous surgeries. Results: The mean age was 63.7 years-old with a mean duration of 40.5 months of clinical follow-up. There were no significant pre-operative differences between simultaneous and staged groups in terms of age, gender, BMI, ASA classification, or arthritis etiology (p>0.05). The majority (54.5%) of patients had primary or secondary arthritis. Comorbidities were similar between the two groups with the exception of the simultaneous cohort having a higher proportion of previous smokers (56.3 vs 26.1, p=0.0020) and coronary artery disease (19.8 vs 6.5, 0.0447). There was no difference in perioperative complications between the groups(p= 0.4652). Both cohorts significantly improved in all reported patient reported outcomes at final follow-up (<0.001) without a difference in overall improvement between groups (p >0.05) (Table 1). Conclusion: The prevalence of osteoarthritis (primary arthritis) and inflammatory arthritis (secondary arthritis) was higher in patients with bilateral end-stage arthritis necessitating a TAR than previous reports of unilateral TAR. The results of bilateral simultaneous TAA, including perioperative complications and patient reported outcomes, are comparable to patients undergoing staged TAA. We advocate that simultaneous bilateral TAA is a safe and effective method the treatment of bilateral end-stage ankle osteoarthritis in a setting where experienced surgeons are available. Potential benefits of simultaneous TAR for further investigation include decreased: anesthesia events, surgery time, length of hospitalization, recovery and rehabilitation time, and overall cost.
first_indexed 2024-12-20T23:32:15Z
format Article
id doaj.art-bbf09ade4b3347f3a7b4b4d498a2df8c
institution Directory Open Access Journal
issn 2473-0114
language English
last_indexed 2024-12-20T23:32:15Z
publishDate 2020-10-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj.art-bbf09ade4b3347f3a7b4b4d498a2df8c2022-12-21T19:23:17ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142020-10-01510.1177/2473011420S00211Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?Amanda N. Fletcher MDGregory F. Pereira MDMark E. Easley MDJames A. Nunley MDJames K. DeOrio MDCategory: Ankle; Ankle Arthritis Introduction/Purpose: The utilization of total ankle arthroplasty has increased over the past decade, including bilateral TARs. The risk-benefit profiles of staged versus simultaneous joint arthroplasty continues to be debated in the literature. Previous studies of the hip and knee have demonstrated simultaneous bilateral surgery is associated with shorter hospitalization, shorter recovery and rehabilitation time, and decreased cost without increasing perioperative morbidity or mortality. There are limited case series reporting outcomes after bilateral TAR with no previous comparison of simultaneous versus staged TAR. Thus, we aim to compare our experience with bilateral simultaneous versus staged TARs including perioperative complications and patient reported outcomes. Methods: We performed a retrospective study on 62 patients (124 ankles) undergoing primary TAA (CPT 27702) from 2008 at a single academic center. Inclusion criteria were primary bilateral TAA performed in staged or simultaneous fashion in patients over the age of 18 years-old. Exclusion criteria were patients with less than one-year follow-up. Patient demographics, comorbidities, concomitant procedures, perioperative complications, and patient reported outcomes were also collected. Patient reported outcomes included preoperative and postoperative visual analog scale (VAS) for pain, the Short Form-36 (SF-36) Health Survey, the American Orthopaedic Foot & Ankle Society (AOFAS) score, the Foot and Ankle disability Index (FADI) score, and the Short Musculoskeletal Function Assessment (SMFA) bother and function sub-scores. Every patient had separate outcome scores available for each ankle. Univariate and multivariable tests of significance were used to relate patient and operative characteristics to outcomes. Separate subgroup analyses were performed comparing stages versus simultaneous surgeries. Results: The mean age was 63.7 years-old with a mean duration of 40.5 months of clinical follow-up. There were no significant pre-operative differences between simultaneous and staged groups in terms of age, gender, BMI, ASA classification, or arthritis etiology (p>0.05). The majority (54.5%) of patients had primary or secondary arthritis. Comorbidities were similar between the two groups with the exception of the simultaneous cohort having a higher proportion of previous smokers (56.3 vs 26.1, p=0.0020) and coronary artery disease (19.8 vs 6.5, 0.0447). There was no difference in perioperative complications between the groups(p= 0.4652). Both cohorts significantly improved in all reported patient reported outcomes at final follow-up (<0.001) without a difference in overall improvement between groups (p >0.05) (Table 1). Conclusion: The prevalence of osteoarthritis (primary arthritis) and inflammatory arthritis (secondary arthritis) was higher in patients with bilateral end-stage arthritis necessitating a TAR than previous reports of unilateral TAR. The results of bilateral simultaneous TAA, including perioperative complications and patient reported outcomes, are comparable to patients undergoing staged TAA. We advocate that simultaneous bilateral TAA is a safe and effective method the treatment of bilateral end-stage ankle osteoarthritis in a setting where experienced surgeons are available. Potential benefits of simultaneous TAR for further investigation include decreased: anesthesia events, surgery time, length of hospitalization, recovery and rehabilitation time, and overall cost.https://doi.org/10.1177/2473011420S00211
spellingShingle Amanda N. Fletcher MD
Gregory F. Pereira MD
Mark E. Easley MD
James A. Nunley MD
James K. DeOrio MD
Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?
Foot & Ankle Orthopaedics
title Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?
title_full Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?
title_fullStr Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?
title_full_unstemmed Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?
title_short Two for One: Bilateral Simultaneous versus Staged Total Ankle Arthroplasty, are Patient-Centered Outcomes Equivalent?
title_sort two for one bilateral simultaneous versus staged total ankle arthroplasty are patient centered outcomes equivalent
url https://doi.org/10.1177/2473011420S00211
work_keys_str_mv AT amandanfletchermd twoforonebilateralsimultaneousversusstagedtotalanklearthroplastyarepatientcenteredoutcomesequivalent
AT gregoryfpereiramd twoforonebilateralsimultaneousversusstagedtotalanklearthroplastyarepatientcenteredoutcomesequivalent
AT markeeasleymd twoforonebilateralsimultaneousversusstagedtotalanklearthroplastyarepatientcenteredoutcomesequivalent
AT jamesanunleymd twoforonebilateralsimultaneousversusstagedtotalanklearthroplastyarepatientcenteredoutcomesequivalent
AT jameskdeoriomd twoforonebilateralsimultaneousversusstagedtotalanklearthroplastyarepatientcenteredoutcomesequivalent